U
Ulf Neisius
Researcher at Beth Israel Deaconess Medical Center
Publications - 36
Citations - 788
Ulf Neisius is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Coronary artery disease & Hypertrophic cardiomyopathy. The author has an hindex of 14, co-authored 34 publications receiving 534 citations. Previous affiliations of Ulf Neisius include VA Boston Healthcare System & University of Glasgow.
Papers
More filters
Journal ArticleDOI
Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals.
Christian Delles,Eric Schiffer,Constantin von zur Mühlen,Karlheinz Peter,Peter Rossing,Hans-Henrik Parving,Jane A. Dymott,Ulf Neisius,Lukas Zimmerli,Janet K. Snell-Bergeon,David M. Maahs,Roland E. Schmieder,Harald Mischak,Anna F. Dominiczak +13 more
TL;DR: Urinary proteomics identifies CAD with high confidence and might also be useful for monitoring the effects of therapeutic interventions.
Journal ArticleDOI
Radiomic Analysis of Myocardial Native T1 Imaging Discriminates Between Hypertensive Heart Disease and Hypertrophic Cardiomyopathy.
Ulf Neisius,Hossam El-Rewaidy,Shiro Nakamori,Jennifer Rodriguez,Warren J. Manning,Reza Nezafat +5 more
TL;DR: Radiomics analysis of native T1 images discriminates between HHD and HCM patients and provides incremental value over global native T 1 mapping.
Journal ArticleDOI
Automated Cardiac MR Scar Quantification in Hypertrophic Cardiomyopathy Using Deep Convolutional Neural Networks
Ahmed S. Fahmy,Johannes Rausch,Ulf Neisius,Raymond H. Chan,Martin S. Maron,Evan Appelbaum,Bjoern H. Menze,Reza Nezafat +7 more
TL;DR: Scar volume quantified by cardiovascular magnetic resonance (CMR) with late gadolinium enhancement (LGE) is a novel imaging biomarker for risk stratification in patients with hypertrophic cardiomyopathy (HCM).
Journal ArticleDOI
Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy.
Ulf Neisius,Lana Myerson,Ahmed S. Fahmy,Shiro Nakamori,Hossam El-Rewaidy,Gargi Joshi,Chong Duan,Warren J. Manning,Reza Nezafat +8 more
TL;DR: CMR-FT GLS differentiates between HHD and HCM patients and is associated with myocardial fibrosis, similar to LV hypertrophy and fibrosis imaging markers.
Journal ArticleDOI
Association of central and peripheral pulse pressure with intermediate cardiovascular phenoytpes
Ulf Neisius,Grzegorz Bilo,Chiara Taurino,John D. McClure,M. Schneider,Kalina Kawecka-Jaszcz,Katarzyna Stolarz-Skrzypek,Łukasz Klima,Jan A. Staessen,Tatiana Kuznetsova,Josep Redon,Fernando Martinez,Enrico Agabiti Rosei,Maria Lorenza Muiesan,Olle Melander,Faiez Zannad,Patrick Rossignol,Stéphane Laurent,Cédric Collin,Laura Lonati,Alberto Zanchetti,Anna F. Dominiczak,Christian Delles +22 more
TL;DR: In a middle-aged cohort with high prevalence of hypertension cPP is more closely correlated with cardiovascular phenotypes than pPP, however, cPP does not provide additional information beyond pPP when adjusted for relevant cofactors.